Matthew is a Health Policy Analyst in our Life Sciences Health Industry Group. Drawing on nearly a decade of experience at Bloomberg Law – where he served as the Practice Lead for their Health Care Group – along with a background as a practicing lawyer and law clerk, Matt monitors federal and state policy developments coming out of CMS, OIG, HHS, FDA and other federal and state agencies.
He focuses primarily on federal and state health laws and regulations; Medicare and Medicaid payment systems; health care fraud & abuse litigation and enforcement; health care transaction regulation; and pharmaceutical manufacturing and distribution regulation, helping health care and life sciences clients understand and implement changes in health care policy.
In addition, Matt is the editor of Reed Smith's "Health Industry Washington Watch" blog, which offers ongoing reporting of legislative and regulatory developments affecting Medicare and Medicaid reimbursement, fraud and abuse developments and other health care regulatory changes. He also is a frequent author of articles and analyses regarding federal health policy.
